Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis
Metabolic reprogramming has been recognized as an essential emerging cancer hallmark. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been reported to have anti-cancer effects by reversing tumor-associated glycolysis. This study was performed to explore the anti-cance...
Enregistré dans:
Auteurs principaux: | Aya Al-Azawi, Shahrazad Sulaiman, Kholoud Arafat, Javed Yasin, Abderrahim Nemmar, Samir Attoub |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c5c9c3cf955e4727b2ab0e54c79be468 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells
par: Rosalba Florio, et autres
Publié: (2018) -
Hemolytic anemia caused by hereditary pyruvate kinase deficiency in a West Highland White Terrier dog
par: Hlavac,NRC, et autres
Publié: (2012) -
Pyruvate Homeostasis as a Determinant of Parasite Growth and Metabolic Plasticity in <named-content content-type="genus-species">Toxoplasma gondii</named-content>
par: Ningbo Xia, et autres
Publié: (2019) -
Expanding Primary Metabolism Helps Generate the Metabolic Robustness To Facilitate Antibiotic Biosynthesis in <italic toggle="yes">Streptomyces</italic>
par: Jana K. Schniete, et autres
Publié: (2018) -
Detection of Nail Oncometabolite SAICAR in Oral Cancer Patients and Its Molecular Interactions with PKM2 Enzyme
par: Rushikesh Patel, et autres
Publié: (2021)